Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Amgen to Acquire a Leading Turkish API Producer
1:13 AM MDT | May 1, 2012 | Deepti Ramesh
Amgen (Thousand Oaks, CA) says it has signed an agreement to acquire 95.6% stake in Mustafa Nevzat Pharmaceuticals (Istanbul, Turkey), a privately held pharmaceutical company, for about $700 million. Mustafa Nevzat Pharmaceuticals is one of the leading manufacturers of active pharmaceutical ingredients (APIs) and finished dosage forms in Turkey. Mustafa Nevzat Pharmaceuticals had revenues of about $200 million in 2011 and has grown on average at double-digit rates in local currency over the past five years, Amgen says. The API manufacturing complex of Mustafa...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee